Current and emergent strategies for disinfection of hospital environments

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2718-2732

  Abreu, Ana C ^a   Tavares, Rafaela R ^a   Borges, Anabela ^a   Mergulhão, Filipe ^a   Simões, Manuel ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Antimicrobial resistance; Cross contamination; Disinfection; Hospital acquired infections

Indexed keywords

2 PROPANOL; ALCOHOL; ALCOHOL DERIVATIVE; AMMONIA; ANTIINFECTIVE AGENT; BIOCIDE; CETYLPYRIDINIUM SALT; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; CHLORINE DIOXIDE; DISINFECTANT AGENT; FORMALDEHYDE; GLUTARALDEHYDE; GUANIDINE; HYDROGEN PEROXIDE; HYPOCHLORITE; INORGANIC SALT; PERACETIC ACID; PHTHALALDEHYDE; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; PROPANOL; QUATERNARY AMMONIUM DERIVATIVE; SILVER; SODIUM CHLORIDE; SPORICIDIN; STAINLESS STEEL; TOSYLCHLORAMIDE SODIUM; TROCLOSENE; UNINDEXED DRUG;

ACINETOBACTER BAUMANNII; ADENOVIRUS; ARTICLE; BORDETELLA PERTUSSIS; CANDIDA; CHLAMYDIA; CLOSTRIDIUM DIFFICILE; CORONAVIRUS; CORYNEBACTERIUM; DISINFECTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS HIRAE; ENVIRONMENT; ESCHERICHIA COLI; GAS; GEOBACILLUS STEAROTHERMOPHILUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS; HOSPITAL; HOSPITAL INFECTION; INFLUENZA; KLEBSIELLA; MEDICAL DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROORGANISM; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; ROTAVIRUS; SARS CORONAVIRUS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VANCOMYCIN RESISTANT ENTEROCOCCUS; VAPOR;

ANTIMICROBIAL RESISTANCE; CROSS-CONTAMINATION; DISINFECTION; HOSPITAL-ACQUIRED INFECTIONS;

CROSS INFECTION; DISINFECTION; ENVIRONMENTAL MICROBIOLOGY; HOSPITALS; HUMANS;

EID: 84887514856     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt281     Document Type: Article

References (150)

1. Talon D. The role of the hospital environment in the epidemiology of multi-resistant bacteria. J Hosp Infect 1999; 43: 13-7.
2. Schelz Z, Hohmann J, Molnar J. Recent advances in research of antimicrobial effects of essential oils and plant derived compounds on bacteria. In: Chattopadhyay D, ed. Ethnomedicine: A Source of Complementary Therapeutics. Kerala: Research Signpost, 2010; 179-201.
3. Dötsch A, Becker T, Pommerenke C et al. Genomewide identification of genetic determinants of antimicrobial drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 56: 2522-31.
4. Guz NR, Stermitz FR, Johnson JB et al. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. J Med Chem 2000; 44: 261-8.
5. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999; 2: 489-93.
6. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol 2003; 6: 452-6.
7. Guillemot D. Antibiotic use in humans and bacterial resistance. Curr Opin Microbiol 1999; 2: 494-8.
8. Monroe S, Polk R. Antimicrobial use and bacterial resistance. Curr Opin Microbiol 2000; 3: 496-501.
9. Cotter JJ, Maguire P, Soberon F et al. Disinfection of meticillin-resistant Staphylococcus aureus and Staphylococcus epidermidis biofilms using a remote non-thermal gas plasma. J Hosp Infect 2011; 78: 204-7.
10. Joshi SG, Paff M, Friedman G et al. Control of methicillin-resistant Staphylococcus aureus in planktonic form and biofilms: a biocidal efficacy study of nonthermal dielectric-barrier discharge plasma. Am J Infect Control 2010; 38: 293-301.
11. RutalaWA,Weber DJ. Surface disinfection: shouldwe doit? J Hosp Infect 2001; 48: S64-8.
12. Zollfrank C, Gutbrod K, Wechsler P et al. Antimicrobial activity of transition metal acid MoO3 prevents microbial growth on material surfaces. Mater Sci Eng C Mater Biol Appl 2012; 32: 47-54.
13. Pinto MS, McGahan ME, Steiner WW et al. The use of the pseudopolyelectrolyte, poly(4-vinylphenol), in multilayered films as an antimicrobial surface coating. Colloids Surf A Physicochem Eng Asp 2011; 377: 182-6.
14. Griffith CJ, Cooper RA, Gilmore J et al. An evaluation of hospital cleaning regimes and standards. J Hosp Infect 2000; 45: 19-28.
15. Weber DJ, Rutala WA, Miller MB et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010; Suppl 1: S25-33.
16. CozadA, Jones RD. Disinfectionandthe prevention of infectious disease. Am J Infect Control 2003; 31: 243-54.
17. Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 2011; 32: 687-99.
18. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28: 1062-8.
19. Wach J-Y, Bonazzi S, Gademann K. Antimicrobial surfaces through natural product hybrids. Angew Chem Int Ed 2008; 47: 7123-6.
20. Burts ML, Alexeff I, Meek ET et al. Use of atmospheric non-thermal plasma as a disinfectant for objects contaminated with methicillin-resistant Staphylococcus aureus. Am J Infect Control 2009; 37: 729-33.
21. Madigan M, Martinko J, Parker J. Brock Biology of Microorganisms. Sao Paulo: Prentice Hall, 2004.
22. Madkour AE, Dabkowski JM, Nusslein K et al. Fast disinfecting antimicrobial surfaces. Langmuir 2009; 25: 1060-7.
23. Sexton JD, Tanner BD, Maxwell SL et al. Reduction in the microbial load on high-touch surfaces in hospital rooms by treatment with a portable saturated steam vapor disinfection system. Am J Infect Control 2011; 39: 655-62.
24. Simões M, Simões LC, Cleto S et al. Antimicrobial mechanisms of ortho-phthalaldehyde action. J Basic Microbiol 2007; 47: 230-42.
25. Pitten FA,WernerHP, KramerA.Astandardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 2003; 55: 108-15.
26. Carling PC, Von Beheren S, Kim P et al. Intensive care unit environmental cleaning: an evaluation in sixteen hospitals using a novel assessment tool. J Hosp Infect 2008; 68: 39-44.
27. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
28. Olson M, Ceri H, Morck D et al. Biofilm bacteria: formation and comparative susceptibility to antibiotics. Can J Vet Res 2002; 66: 86-92.
29. Toté K, Berghe DV, Deschacht M et al. Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Int J Antimicrob Agents 2009; 33: 525-31.
30. Simões M. Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem 2011; 18: 2129-45.
31. Simões M, Simões LC, Vieira MJ. A review of current and emergent biofilm control strategies. Food Sci Technol 2010; 43: 573-83.
32. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006; 6: 130.
33. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004; 39: 1182-9.
34. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 2004; 56: 10-5.
35. Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 2007; 65: 50-4.
36. Hirai Y. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 1991; 19: 191-200.
37. Boyce JM, Potter-Bynoe G, Chenevert C et al. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18: 622-7.
38. Falagas ME, Thomaidis PC, Kotsantis IK et al. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 2011; 78: 171-7.
39. Dancer SJ. Mopping up hospital infection. J Hosp Infect 1999; 43: 85-100.
40. Cheng KL, Boost MV, Chung JWY. Study on the effectiveness of disinfection with wipes against methicillin-resistant Staphylococcus aureus and implications for hospital hygiene. Am J Infect Control 2011; 39: 577-80.
41. Drees M, Snydman DR, Schmid CH et al. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008; 46: 678-85.
42. Dancer SJ, White LF, Lamb J et al. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009; 7: 28.
43. Microbiology Advisory Committee. Decontamination of Equipment, Linen or Other Surfaces Contaminated with Hepatitis B and/or Human Immunodeficiency Viruses. Department of Health, London, 1991.
44. Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect 2009; 73: 378-85.
45. Wilcox MH, Fawley WN, Wigglesworth N et al. Comparison of the effect of detergent versushypochlorite cleaningonenvironmentalcontamination and incidence of Clostridium difficile infection. J Hosp Infect 2003; 54: 109-14.
46. Wood MW, Lund RC, Stevenson KB. Bacterial contamination of stethoscopes with antimicrobial diaphragm covers. Am J Infect Control 2007; 35: 263-6.
47. Berendt AE, Turnbull L, Spady D et al. Three swipes and you re out: how many swipes are needed to decontaminate plastic with disposable wipes?. Am J Infect Control 2011; 39: 442-3.
48. Cotterill S, Evans R, Fraise AP. An unusual source for an outbreak of methicillin-resistant Staphylococcus aureus on an intensive therapy unit. J Hosp Infect 1996; 32: 207-16.
49. Kampf G, Rudolf M, Labadie JC et al. Spectrum of antimicrobial activity and user acceptability of the hand disinfectant agent Sterilliumw ® Gel. J Hosp Infect 2002; 52: 141-7.
50. Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J Hosp Infect 2004; 58: 42-9.
51. Pessoa-Silva CLMD, Dharan SMT, Hugonnet SMDM et al. Dynamics of bacterial hand contamination during routine neonatal care. Infect Control Hosp Epidemiol 2004; 25: 192-7.
52. Pittet D, Dharan S, Touveneau S et al. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med 1999; 159: 821-6.
53. Fendler EJ, Ali Y,HammondBS et al. The impact of alcohol handsanitizer use on infection rates in an extended care facility.AmJ Infect Control 2002; 30: 226-33.
54. Hilburn J,HammondBS, Fendler EJ et al. Use of alcohol hand sanitizeras an infection control strategy in an acute care facility. Am J Infect Control 2003; 31: 109-16.
55. Page K,Wilson M, Parkin IP. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 2009; 19: 3819-31.
56. Lopez P-J, Ron O, Parthasarathy P et al. Bacterial counts from hospital doctors ties are higher than those from shirts. Am J Infect Control 2009; 37: 79-80.
57. Rutala WA, Weber DJ. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Healthcare Infection Control Practices Advisory Committee (HICPAC). Atlanta, GA, USA: CDC.
58. Rutala WA, Weber DJ. Sterilization, high-level disinfection, and environmental cleaning. Infect Dis Clin North Am 2011; 25: 45-76.
59. Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 2004; 39: 702-9.
60. Russell AD. Bacterial resistance to disinfectants: present knowledgeand future problems. J Hosp Infect 1999; 43: S57-68.
61. Fraise AP. Choosing disinfectants. J Hosp Infect 1999; 43: 255-64.
62. Rutala WA, Weber DJ. Infection control: the role of disinfection and sterilization. J Hosp Infect 1999; 43: S43-55.
63. McDonnell G, Burke P. Disinfection: is it time to reconsider Spaulding? J Hosp Infect 2011; 78: 163-70.
64. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 1999; 12: 147-79.
65. Sagripanti J-L, Bonifacino A. Bacterial spores survive treatment with commercial sterilants and disinfectants. Appl Environ Microbiol 1999; 65: 4255-60.
66. Russell AD. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J Hosp Infect 2004; 57: 97-104.
67. Russell AD. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. J Appl Microbiol 2002; 92 Suppl: 121S-35S.
68. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 2003; 16: 189-208.
69. Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 1997; 10: 597-610.
70. Bermudez-Aguirre D, Barbosa-Canovas GV. Disinfection of selected vegetables under nonthermal treatments: chlorine, acid citric, ultraviolet light and ozone. Food Control 2013; 29: 82-90.
71. Denyer SP, Stewart GSAB. Mechanisms of action of disinfectants. Int Biodeter Biodegr 1998; 41: 261-8.
72. Russell AD. Similarities and differences in the responses of microorganisms to biocides. J Antimicrob Chemother 2003; 52: 750-63.
73. Griffiths PA, Babb JR, Fraise AP. Mycobactericidal activity of selected disinfectants using a quantitative suspension test. J Hosp Infect 1999; 41: 111-21.
74. Théraud M, Bedouin Y, Guiguen C et al. Efficacy of antiseptics and disinfectants on clinical and environmental yeast isolates in planktonic and biofilm conditions. J Med Microbiol 2004; 53: 1013-8.
75. Oie S, Yanagi C,MatsuiH et al. Contamination of environmental surfaces by Staphylococcus aureus in a dermatological ward and its preventive measures. Biol Pharm Bull 2005; 28: 120-3.
76. Speight S, Moy A, Macken S et al. Evaluation of the sporicidal activity of different chemical disinfectants used in hospitals against Clostridium difficile. J Hosp Infect 2011; 79: 18-22.
77. Kim H, Ryu J-H, Beuchat LR. Effectiveness of disinfectants in killing Enterobacter sakazakii in suspension, dried on the surface of stainless steel, and in a biofilm. Appl Environ Microbiol 2007; 73: 1256-65.
78. Bridier A, Briandet R, Thomas V et al. Comparative biocidal activity of peracetic acid, benzalkonium chloride and ortho-phthalaldehyde on 77 bacterial strains. J Hosp Infect 2011; 78: 208-13.
79. Gutierrez-Marti{dotless}n CB, Yubero S, Marti{dotless}nez S et al. Evaluation of efficacy of several disinfectants against Campylobacter jejuni strains by a suspension test. Res Vet Sci 2011; 91: e44-7.
80. Siani H, Cooper C, Maillard J-Y. Efficacy of sporicidal wipes against Clostridium difficile. Am J Infect Control 2011; 39: 212-8.
81. Giannini MA, Nance D, McCullers JA. Are toilet seats a vector for transmission of methicillin-resistant Staphylococcus aureus? Am J Infect Control 2009; 37: 505-6.
82. Williams GJ, Denyer SP, Hosein IK et al. The development of a new three-step protocol to determine the efficacy of disinfectant wipes on surfaces contaminated with Staphylococcus aureus. J Hosp Infect 2007; 67: 329-35.
83. Rutala WA, Weber DJ. New disinfection and sterilization methods. Emerging Infect Dis 2001; 7: 348-53.
84. Tanner BD. Reduction in infection risk through treatment of microbially contaminated surfaces with a novel, portable, saturated steam vapor disinfection system. Am J Infect Control 2009; 37: 20-7.
85. Otter JA, French GL. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 2009; 47: 205-7.
86. Hall L, Otter JA, Chewins J et al. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 2007; 45: 810-5.
87. McDonnell G. Hydrogen peroxide fogging/fumigation. J Hosp Infect 2006; 62: 385-6.
88. Boyce JM, Havill NL, Moore BA. Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol 2011; 32: 737-42.
89. Rutala WA, Gergen MF, Weber DJ. Room decontamination with UV radiation. Infect Control Hosp Epidemiol 2010; 31: 1025-9.
90. Sambol AR, Iwen PC. Biological monitoring of ultraviolet germicidal irradiation in a biosafety level 3 laboratory. Appl Biosaf 2006; 11: 81-7.
91. Weber DJ, Rutala WA. Self-disinfecting surfaces. Infect Control Hosp Epidemiol 2012; 33: 10-3.
92. Rutala WA, Weber DJ. Are room decontamination units needed to prevent transmission of environmental pathogens? Infect Control Hosp Epidemiol 2011; 32: 743-7.
93. Zhang X, Huang X, Jiang L et al. Surface microstructures and antimicrobial properties of copper plasma alloyed stainless steel. Appl Surf Sci 2011; 258: 1399-404.
94. Héquet A, Humblot V, Berjeaud J-M et al. Optimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance tests. Colloid Surface B 2011; 84: 301-9.
95. Tiller JC. Coatings for prevention or deactivation of biological contamination. In: Kohli R, Mittal KL, eds. Developments in Surface Contamination and Cleaning. Norwich, NY, USA: William Andrew, 2008; 1013-65.
96. Tian XB, Wang ZM, Yang SQ et al. Antibacterial copper-containing titanium nitride films produced by dual magnetron sputtering. Surf Coat Technol 2007; 201: 8606-9.
97. DunnillCW, Page K, Aiken ZA et al. Nanoparticulate silver coated-titania thin films - photo-oxidative destruction of stearic acid under different light sources and antimicrobial effects under hospital lighting conditions. J Photochem Photobiol A 2011; 220: 113-23.
98. Balazs DJ, Triandafillu K,WoodPet al. Inhibition of bacterial adhesionon PVC endotracheal tubes by RF-oxygen glow discharge, sodium hydroxide and silver nitrate treatments. Biomaterials 2004; 25: 2139-51.
99. Siedenbiedel F, Tiller JC. Antimicrobial polymers in solution and on surfaces: overview and functional principles. Polymers 2012; 4: 46-71.
100. Kühn KP, Chaberny IF, Massholder K et al. Disinfection of surfaces by photocatalytic oxidation with titanium dioxide and UVA light. Chemosphere 2003; 53: 71-7.
101. Goddard JM, Hotchkiss JH. Polymer surface modification for the attachment of bioactive compounds. Prog Polym Sci 2007; 32: 698-725.
102. Kenawy E-R,Worley SD, Broughton R. The chemistry and applications of antimicrobial polymers: a state-of-the-art review. Biomacromolecules 2007; 8: 1359-84.
103. Ristic T, Zemljic LF, Novak M et al. Antimicrobial efficiency of functionalized cellulose fibres as potentialmedical textiles. In: Mendez-Vilas A, ed. Science Against Microbial Pathogens: Communicating Current Research and Technological Advances. Badajoz, Spain: Formatex, 2011; 36-51.
104. Lichter JA, Rubner MF. Polyelectrolyte multilayers with intrinsic antimicrobial functionality: the importance of mobile polycations. Langmuir 2009; 25: 7686-94.
105. Moisan M, Barbeau J, Moreau S et al. Low-temperature sterilization using gas plasmas: a review of the experiments and an analysis of the inactivation mechanisms. Int J Pharm 2001; 226: 1-21.
106. Moreau M,OrangeN, FeuilloleyMGJ.Non-thermal plasmatechnologies: new tools for bio-decontamination. Biotechnol Adv 2008; 26: 610-7.
107. Morfill GE, Shimizu T, Steffes B et al. Nosocomial infections - a new approach towards preventive medicine using plasmas. New J Phys 2009; 11: 1-10.
108. Shimizu T, Zimmermann JL, Morfill GE. The bactericidal effect of surface micro-discharge plasma under different ambient conditions. New J Phys 2011; 13: 1-7.
109. Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician 2006; 74: 420-6.
110. Hanna HMD, Raad IMD, Gonzalez VBS et al. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 2000; 21: 226-8.
111. Sinh P, Barrett TA, Yun L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract 2011; 2011: 136064.
112. Kuo CC, Jackson LA, Campbell LA et al. Chlamydia pneumoniae(TWAR). Clin Microbiol Rev 1995; 8: 451-61.
113. Campbell LA, Kuo CC. Chlamydia pneumoniae pathogenesis. J Med Microbiol 2002; 51: 623-5.
114. Bonnet JM, Begg NT. Control of diphtheria: guidance for consultants in communicable disease control. Commun Dis Public Health 1999; 2: 242-9.
115. Murphy JR. Corynebacterium diphtheriae. In: Baron S, ed. Medical Microbiology. Galveston, TX: University of Texas Medical Branch at Galveston, 1996; Chapter 32.
116. Oprea SF, Zervos MJ. Enterococcus and its association with foodborne illness. In: Simjee S, ed. Foodborne Disease. Totowa, NJ: Humana Press, 2007; 157-74.
117. Foxwell AR, Kyd JM, Cripps AW. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev 1998; 62: 294-308.
118. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998; 11: 589-603.
119. Engelhart S, Krizek L, Glasmacher A et al. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J Hosp Infect 2002; 52: 93-8.
120. Manning ML, Archibald LK, Bell LM et al. Serratia marcescens transmission in a pediatric intensive care unit: a multifactorial occurrence. Am J Infect Control 2001; 29: 115-9.
121. Passaro DJ, Waring L, Armstrong R et al. Postoperative Serratia marcescens wound infections traced to an out-of-hospital source. J Infect Dis 1997; 175: 992-5.
122. Colbeck JC. Environmental aspects of staphylococcal infections acquired in hospitals. Am J Public Health 1960; 50: 468-73.
123. Nuorti JP. Pneumococcal disease (Streptococcus pneumoniae). In: Brunette GW, Kozarsky PE, Magill AJ et al., eds. CDC Health Information for International Travel. New York: Oxford University Press, 2012; Chapter 3.
124. Bessen DE. Population biology of the human restricted pathogen, Streptococcus pyogenes. Infect Genet Evol 2009; 9: 581-93.
125. Cleary PP, Schlievert PM, Handley JPet al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-21.
126. Pfaller MA. Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. Clin Infect Dis 1996; 22 Suppl 2: S89-94.
127. Queensland Health. Communicable Diseases Control Manual. 5th edn. 2011. Brisbane, Queensland, Australia.
128. Mattner F, Sohr D, Heim A et al. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect 2006; 12: 69-74.
129. Holton J, Shetty N, McDonald V. Efficacyof Nu-Cidex (0.35% peracetic acid) against mycobacteria and cryptosporidia. J Hosp Infect 1995; 31: 235-7.
130. Coates D. Sporicidal activity of sodium dichloroisocyanurate, peroxygen and glutaraldehyde disinfectants against Bacillus subtilis. J Hosp Infect 1996; 32: 283-94.
131. Shetty N, Srinivasan S, Holton J et al. Evaluation of microbicidal activity of a new disinfectant: Sterilox 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicansand severalMycobacterium species. J Hosp Infect 1999;41: 101-5.
132. Vintov J, Aarestrup FM, Zinn CE et al. Association between phage types and antimicrobial resistance among bovine Staphylococcus aureus from10 countries. Vet Microbiol 2003; 95: 133-47.
133. Block C, Robenshtok E, Simhon A et al. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. J Hosp Infect 2000; 46: 147-52.
134. Block C. The effect of Perasafew ®and sodium dichloroisocyanurate (NaDCC) against spores of Clostridium difficile and Bacillus atrophaeus on stainless steel and polyvinyl chloride surfaces. J Hosp Infect 2004; 57: 144-8.
135. Vizcaino-Alcaide MJ, Herruzo-Cabrera R, Fernandez-Acenero MJ. Comparison of the disinfectant efficacy of Perasafew® and 2% glutaraldehyde in in vitro tests. J Hosp Infect 2003; 53: 124-8.
136. Wutzler P, Sauerbrei A, Schau HP. Monopercitric acid - a new disinfectant with excellent activity towards clostridial spores. J Hosp Infect 2005; 59: 75-6.
137. Simões M, Pereira MO, Machado I et al. Comparative antibacterial potential of selected aldehyde-based biocides and surfactants against planktonic Pseudomonas fluorescens. J Ind Microbiol Biotechnol 2006; 33: 741-9.
138. Walsh SE, Maillard JY, Russell AD. Ortho-phthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 1999; 86: 1039-46.
139. Alfa MJ, Sitter DL. In-hospital evaluation of orthophthalaldehyde as a high level disinfectant for flexible endoscopes. J Hosp Infect 1994; 26: 15-26.
140. Oulé MK, Azinwi R, Bernier A-M et al. Polyhexamethylene guanidine hydrochloride-based disinfectant: a novel tool to fight meticillin-resistant Staphylococcus aureus and nosocomial infections. J Med Microbiol 2008; 57: 1523-8.
141. Andersen BM, Rasch M, Kvist J et al. Floor cleaning: effect on bacteria and organic materials in hospital rooms. J Hosp Infect 2009; 71: 57-65.
142. Hedin G, Rynback J, Lore B. Reduction of bacterial surface contamination in the hospital environment by application of a new product with persistent effect. J Hosp Infect 2010; 75: 112-5.
143. Chatuev BM, PetersonJW. Analysis of the sporicidal activity of chlorine dioxide disinfectant against Bacillus anthracis (Sterne strain). J Hosp Infect 2010; 74: 178-83.
144. Horejsh D, Kampf G. Efficacy of three surface disinfectants against spores of Clostridium difficile ribotype 027. Int J Hyg Environ Health 2011; 214: 172-4.
145. Chung C-J, Lin H-I, Tsou H-K et al. An antimicrobial TiO2 coating for reducing hospital-acquiredinfection. J BiomedMater Res 2008;85B:220-4.
146. Shao H, Meng W-D, Qing F-L. Synthesis and surface antimicrobial activity of a novel perfluorooctylated quaternary ammonium silane coupling agent. J Fluorine Chem 2004; 125: 721-4.
147. Foster HA, SheelDW, Sheel P et al. Antimicrobial activity of titania/silver and titania/copper films prepared by CVD. J Photochem Photobiol A 2010; 216: 283-9.
148. XiangyuZ, Ailan F, RuihuaZ et al. Antibacterial propertyandtribological behavior of duplex-surface-treated AISI 304 stainless steel. IEEE Trans Plasma Sci 2011; 39: 1598-605.
149. Belcarz A, Bienias J, Surowska B et al. Studies of bacterial adhesion on TiN, SiO2-TiO2 and hydroxyapatite thin layers deposited on titanium and Ti6Al4 Valloy for medical applications. Thin Solid Films 2010;519:797-803.
150. Kurt P, Wood L, Ohman DE et al. Highly effective contact antimicrobial surfaces via polymer surface modifiers. Langmuir 2007; 23: 4719-23.